Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Screening for latent tuberculous infection in people living with HIV infection in Auckland, New Zealand.

Gow N, Briggs S, Nisbet M.

Int J Tuberc Lung Dis. 2017 Sep 1;21(9):1008-1012. doi: 10.5588/jtld.17.0103.

PMID:
28826450
2.

In reply 2.

Maze MJ, Paynter J, Chiu W, Hu R, Nisbet M, Lewis C.

Int J Tuberc Lung Dis. 2016 Dec;20(12):1696-1697. No abstract available.

PMID:
27931349
3.

Presumed tuberculous uveitis in non-endemic country for tuberculosis: case series from a New Zealand tertiary uveitis clinic.

Ng KK, Nisbet M, Damato EM, Sims JL.

Clin Exp Ophthalmol. 2017 May;45(4):357-365. doi: 10.1111/ceo.12881. Epub 2017 Feb 8.

PMID:
27896896
4.

Bronchiectasis in yellow nail syndrome.

Woodfield G, Nisbet M, Jacob J, Mok W, Loebinger MR, Hansell DM, Wells AU, Wilson R.

Respirology. 2017 Jan;22(1):101-107. doi: 10.1111/resp.12866. Epub 2016 Aug 23.

PMID:
27551950
5.

Increased uptake of cervical screening by women with HIV infection in Auckland regardless of ethnicity, requirement for an interpreter or level of education.

Lowe M, Handy R, Ingram J, Nisbet M, Ritchie S, Thomas M, Briggs S.

N Z Med J. 2016 Jul 15;129(1438):22-31.

PMID:
27447132
6.

Therapeutic drug monitoring of isoniazid and rifampicin during anti-tuberculosis treatment in Auckland, New Zealand.

Maze MJ, Paynter J, Chiu W, Hu R, Nisbet M, Lewis C.

Int J Tuberc Lung Dis. 2016 Jul;20(7):955-60. doi: 10.5588/ijtld.15.0792.

PMID:
27287650
7.

Digital Cognitive Behavioural Therapy for Insomnia versus sleep hygiene education: the impact of improved sleep on functional health, quality of life and psychological well-being. Study protocol for a randomised controlled trial.

Espie CA, Luik AI, Cape J, Drake CL, Siriwardena AN, Ong JC, Gordon C, Bostock S, Hames P, Nisbet M, Sheaves B, G Foster R, Freeman D, Costa-Font J, Emsley R, Kyle SD.

Trials. 2016 May 23;17(1):257. doi: 10.1186/s13063-016-1364-7.

8.

Paediatric empyema in New Zealand.

Briggs S, Duffy E, Handy R, Nisbet M, Ritchie S, Thomas M.

N Z Med J. 2015 Sep 4;128(1421):77-8. No abstract available.

PMID:
26370763
9.

HIV-associated tuberculosis in Auckland.

Luey C, Milne D, Briggs S, Thomas M, Handy R, Nisbet M.

N Z Med J. 2015 Jun 12;128(1416):36-43.

PMID:
26117674
10.

Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial.

Ormerod AD, Thomas KS, Craig FE, Mitchell E, Greenlaw N, Norrie J, Mason JM, Walton S, Johnston GA, Williams HC; UK Dermatology Clinical Trials Network’s STOP GAP Team.

BMJ. 2015 Jun 12;350:h2958. doi: 10.1136/bmj.h2958. Erratum in: BMJ. 2017 Mar 21;356:j1462.

11.

Quantifying the contribution of grape hexoses to wine volatiles by high-precision [U¹³C]-glucose tracer studies.

Nisbet MA, Tobias HJ, Brenna JT, Sacks GL, Mansfield AK.

J Agric Food Chem. 2014 Jul 16;62(28):6820-7. doi: 10.1021/jf500947x. Epub 2014 Jul 1. Erratum in: J Agric Food Chem. 2014 Sep 3;62(35):8919.

12.

Uptake, yield and resource requirements of screening for asymptomatic sexually transmissible infections among HIV-positive people attending a hospital outpatient clinic.

Ritchie S, Henley R, Hilton J, Handy R, Ingram J, Mundt S, Nisbet M, Thomas M, Briggs S.

Sex Health. 2014 Mar;11(1):67-72. doi: 10.1071/SH13167.

PMID:
24618022
13.

Understanding public opinion in debates over biomedical research: looking beyond political partisanship to focus on beliefs about science and society.

Nisbet M, Markowitz EM.

PLoS One. 2014 Feb 18;9(2):e88473. doi: 10.1371/journal.pone.0088473. eCollection 2014.

14.
15.

HIV screening in New Zealand: time for a change.

Gow N, Briggs S, Gilmour J, Handy R, Henley R, Ingram J, Kenedi C, Lowe M, Mundt S, Nisbet M, Ritchie S, Thomas M.

N Z Med J. 2013 Sep 13;126(1382):134-6. No abstract available.

PMID:
24154785
16.

How scientists view the public, the media and the political process.

Besley JC, Nisbet M.

Public Underst Sci. 2013 Aug;22(6):644-59. doi: 10.1177/0963662511418743. Epub 2011 Aug 30.

PMID:
23885050
17.

Predicting scientists' participation in public life.

Besley JC, Oh SH, Nisbet M.

Public Underst Sci. 2013 Nov;22(8):971-87. doi: 10.1177/0963662512459315. Epub 2012 Oct 17.

PMID:
23825262
18.
19.

UK Dermatology Clinical Trials Network's STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial.

Craig FF, Thomas KS, Mitchell EJ, Williams HC, Norrie J, Mason JM, Ormerod AD; UK Dermatology Clinical Trials Network’s STOP GAP Trial Team.

Trials. 2012 Apr 28;13:51.

20.

Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.

Freeman JT, McBride SJ, Nisbet MS, Gamble GD, Williamson DA, Taylor SL, Holland DJ.

Int J Infect Dis. 2012 May;16(5):e371-4. doi: 10.1016/j.ijid.2012.01.008. Epub 2012 Mar 7.

Supplemental Content

Loading ...
Support Center